Expanding access to investigational therapies for HIV infection and AIDS : March 12-13, 1990, conference summary /

Saved in:
Bibliographic Details
Author / Creator:Nichols, Eve K.
Imprint:Washington, D.C. : National Academy Press, 1991.
Description:1 online resource (viii, 73 pages)
Language:English
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11200525
Hidden Bibliographic Details
Other authors / contributors:Roundtable for the Development of Drugs and Vaccines against AIDS (Institute of Medicine)
ISBN:058515547X
9780585155470
1280203560
9781280203565
9780309583367
0309583365
0309044901
9780309044905
Digital file characteristics:data file
Notes:Includes bibliographical references.
Restrictions unspecified
Electronic reproduction. [S.l.] : HathiTrust Digital Library, 2010.
Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. http://purl.oclc.org/DLF/benchrepro0212
English.
digitized 2010 HathiTrust Digital Library committed to preserve
Print version record.
Other form:Print version: Nichols, Eve K. Expanding access to investigational therapies for HIV infection and AIDS. Washington, D.C. : National Academy Press, 1991 0309044901
Table of Contents:
  • ""Expanding Access to Investigational Therapies for HIV Infection and AIDS""; ""Copyright""; ""PREFACE""; ""Contents""; ""EXPANDING ACCESS TO INVESTIGATIONAL THERAPIES FOR HIV INFECTION AND AIDS""; ""Expanding Access to Investigational Therapies March 12â€?13, 1990 Program""; ""1 HISTORICAL PERSPECTIVE""; ""EARLY DEVELOPMENT OF EXPANDED ACCESS""; ""Drug Amendments of 1962""; ""Access for Therapeutic Purposes""; ""Growing Confusion""; ""Modern Clinical Trials (Non-AIDS Drugs)""; ""THE ADVENT OF AIDS""; ""Broadening Participation""; ""Accelerating the Pace of Drug Development""
  • ""Improving Response Capabilities""""Expedited Development""; ""Expanded Access""; ""Treatment Investigational New Drugs""; ""Parallel Track""; ""2 RIGHTS AND RESPONSIBILITIES""; ""FREEDOM OF CHOICE""; ""INFORMED CONSENT""; ""Information Resources""; ""Access""; ""Primary Care""; ""Difficult Choices""; ""COMPETING RIGHTS""; ""INSTITUTIONAL REVIEW BOARDS""; ""NEW ATTITUDES""; ""3 EVALUATION OF EXPANDED ACCESS PROGRAMS""; ""TREATMENT INVESTIGATIONAL NEW DRUGS""; ""POTENTIAL RISKS""; ""Examples from the Past""; ""The Target Population""; ""Safety Data""
  • ""IMPACT ON CONVENTIONAL RANDOMIZED TRIALS""""THE PARALLEL TRACK EXPERIMENT""; ""4 CREATIVITY IN CLINICAL TRIALS""; ""THE CHANGING ENVIRONMENT""; ""CONVENTIONAL TRIALS""; ""PREFERENCE TRIALS""; ""LARGE, SIMPLE RANDOMIZED TRIALS""; ""Physician Participation""; ""Quality Control""; ""DATA FROM THE PARALLEL TRACK""; ""Efficacy Data""; ""Safety Data and Related Information""; ""Expectations""; ""5 DRUG INNOVATION AND THE PHARMACEUTICAL INDUSTRY""; ""TIME TO COMMERCIALIZATION""; ""DIRECT COSTS OF EXPANDED ACCESS""; ""Manpower Needs""; ""Drug Costs""; ""The Small Manufacturer""
  • ""PRODUCT LIABILITY""""Concerns Specific to the Parallel Track""; ""Potential Solutions""; ""6 THIRD-PARTY PAYERS""; ""BLUE CROSS AND BLUE SHIELD""; ""HEALTH INSURANCE ASSOCIATION OF AMERICA""; ""HEALTH CARE FINANCING ADMINISTRATION""; ""Medicaid""; ""State Discretion""; ""Patient Care Costs""; ""Medicare""; ""RESOURCES FOR CLINICAL INVESTIGATION""; ""7 IMPROVING ACCESS TO CARE""; ""PEOPLE OF COLOR""; ""Resource Considerations""; ""Suspicion""; ""Informed Consent""; ""WOMEN""; ""The Gender Perspective""; ""Risk Factors""; ""Protocol Development""; ""Women as Vectors""; ""A New Approach""
  • ""THE PEDIATRIC POPULATION""""Scientific Issues""; ""Social Issues""